Big Pharma Update: What Big Pharma is Looking for In Partnering Opportunities
30 September 2009
Thus far, 2009 has marked unprecedented changes and challenges within the biotechnology industry. Big pharma has responded to these challenges through mega mergers, high-profile consolidations, and high-value licensing deals. Couple this with Congress’ impending health care reform measures and pressure to lower drug prices along with changes at the FDA, it is no wonder big pharma is taking dramatic steps to protect and enhance their opportunities for long-term growth. Small to medium-sized life sciences companies have also been forced to make changes as they struggle to retain value, maximize market potential and reduce risks.
In this session, panelists will explore:
- What investment and partnering opportunities are of top priority in the short term?
- Forward looking perspectives about investment and partnering priorities in the future
- Steps small and medium-sized life sciences companies should take to retain and enhance value
Moderator
-
Michael Gunning , Assurance Partner, Pricewaterhouse Coopers
Panelists:
- Roy Cosan, Vice President, Johnson & Johnson Development Corporation
- Stephen B. Maebius, Partner, Foley & Lardner LLP
- Linda Pullan, Ph.D., Pullan Consulting
- James M. Schaeffer, Worldwide Licensing and External Research-West Coast, Merck & Company
Related Insights
19 February 2025
Foley Viewpoints
FinCEN Resumes Corporate Transparency Act Enforcement
The last remaining nationwide injunction prohibiting enforcement of the Corporate Transparency Act (CTA) has been stayed, clearing the way for the federal government to resume enforcing the CTA.
27 February 2025
Events
Coping with Tariff Uncertainty: Managing International Trade Risks Under the Trump Administration
The Trump Administration has issued multiple announcements that it will be sharply raising tariffs on most of the major U.S. trading partners, including 10 percent tariffs on China, 25 percent tariffs on Canada and Mexico (suspended for 30 days), and 25 percent tariffs on all imports of aluminum and steel products.
19 February 2025
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.